Many, if not all, rheumatologists seek to grow as clinicians so they can provide consistently exceptional care to patients and serve as role models for colleagues and trainees. In our Lessons from Master Clinicians series for The Rheumatologist, we present insights from clinicians who have achieved distinction in the field of rheumatology and who are…
Jason Liebowitz, MD, FACR, an assistant professor of medicine at Columbia University Vagelos College of Physicians and Surgeons. He completed undergraduate studies at Johns Hopkins University, Baltimore, where he was inducted into Phi Beta Kappa. He attended medical school at Johns Hopkins School of Medicine and completed his Internal Medicine residency at Johns Hopkins Bayview Medical Center, where he served as chief resident. He completed his rheumatology fellowship at Johns Hopkins Hospital and was honored with the 2019 Distinguished Fellow Award from the American College of Rheumatology. His research and writings have been published in The New England Journal of Medicine, JAMA, JAMA Internal Medicine, Arthritis Care and Research and The Journal of Graduate Medical Education, among other journals. He participated in fellowships with the American Federation for Aging Research (Medical Student Training in Aging Research), the American Austrian Foundation (Max Kade Clinical Clerkship in Vienna, Austria), and the fellowships at Auschwitz for the Study of Professional Ethics (through Yale School of Medicine). He is a co-editor of the textbook Clinical Innovation in Rheumatology: Past, Present, and Future, a co-editor of the book Masterclass in Medicine: Lessons from the Experts, and a co-editor of the textbook series Interdisciplinary Rheumatology.
Articles by Jason Liebowitz, MD, FACR
DADA2: A New Disease for Rheumatologists to Understand
BETHESDA, MD—Rheumatologists from the National Institutes of Health (NIH) and from Jerusalem, Israel, have identified deficiency of adenosine deaminase 2 (DADA2) as an important cause of familial polyarteritis nodosa, which tends to present in childhood and can manifest with hematologic, immunologic and inflammatory signs, says Chip Chambers, MD, founder and president of the DADA2 Foundation….
Complications to Watch for in Pregnant Rheumatology Patients
BALTIMORE—Understanding issues regarding pregnancy in women with rheumatic disease is important to patients and physicians alike, said Bonnie Bermas, MD, the Dr. Morris Ziff Distinguished Professor in Rheumatology at UT Southwestern Medical Center, Dallas, in her recent lecture at the Maryland Society for the Rheumatic Diseases.The physiologic changes in normal pregnancy, which include increased circulating…
Improve Your Recognition & Treatment of Osteoporosis
BALTIMORE—Rheumatologists may not think about osteoporosis on a daily basis, but they should, said Dr. Karl Insogna, the Ensign Professor of Medicine at Yale University School of Medicine and director of the Yale Bone Center in New Haven, Conn., in his recent lecture at the Maryland Society for the Rheumatic Diseases. With approximately 75 million…
Exciting Advances in Giant Cell Arteritis Diagnosis & Treatment
Baltimore—Rheumatologists and meteorologists share more in common than you might suspect, said Dr. Rebecca Manno, assistant professor of medicine for the Division of Rheumatology at Johns Hopkins University, Baltimore, and assistant director of the Johns Hopkins Vasculitis Center. At a March 8 meeting of the Maryland Society for the Rheumatic Diseases, Dr. Manno used the…
- « Previous Page
- 1
- …
- 15
- 16
- 17